Bipolar Disorder Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 65 years, of any gender, who are experiencing a moderate to severe major depressive episode (based on standard psychiatric criteria and a specific symptom score of 19 or above on a rating scale called the MADRS)
- People who have health insurance coverage
- People who have given written consent and agreed to follow the study procedures through to completion
- People for whom there is some uncertainty about whether they may have bipolar disorder, and/or who have one or more of the following: more than 3 depressive episodes in their lifetime; psychotic symptoms; a family member with bipolar disorder; a first depressive episode before the age of 25; unusual or mixed symptoms during depressive episodes; a history of addiction; a personal history of suicide attempts; a lack of response to antidepressants; or depression that began within 6 months of giving birth
Who may not be able to join:
- People whose depression is connected to a diagnosis of schizophrenia or autism spectrum disorder
- People who already have a confirmed diagnosis of bipolar disorder
- People who are already taking a medication called a mood stabiliser
- People with serious physical health conditions that could interfere with follow-up care or that are linked to treatments that may carry a risk of triggering a manic episode
- People with a neurodegenerative disease (a condition where the nervous system progressively deteriorates, such as Parkinson's or Alzheimer's disease)
- People who are pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33788970700
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Improvement in depressive symptoms between inclusion and 15-16 weeks visit.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.